New Hope in Depression Research - PsyRx Reports Promising Findings from an Ibogaine Study
The study, conducted in 105 mice, examined the effects of ibogaine, citalopram and their combination on behavioral measures associated with depression and anxiety TEL AVIV, Israel, Oct. 21, 2026 /PRNewswire/ -- PsyRx (TASE: PSRX) reports that it has received results from a preclinical...
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


